Participants 35 106 6
previously treated, PD-L1-positive, advanced non-small-cell lung cancer
Participants 363 449 5
patients with previously treated, PD-L1-positive, advanced non-small-cell lung cancer.
Participants 513 557 6
202 academic medical centres in 24 countries
Participants 559 671 6
Patients with previously treated non-small-cell lung cancer with PD-L1 expression on at least 1% of tumour cells
Participants 1319 1344 8
we enrolled 1034 patients
Participants 3177 3262 4
patients with previously treated, PD-L1-positive, advanced non-small-cell lung cancer
